Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Exploration of Women's Experiences and Technology Usage Before, During, and After Pregnancy in Singapore

8. november 2021 opdateret af: Prof. Dean Ho, National University of Singapore
This study seek to understand the motivations and contextual influences that can induce and sustain behaviour change to inform future interventions for women before, during and after pregnancy, through a qualitative interview-based assessment of 60 participants. As digital health intervention in pregnant women has been shown to be cost-effective and scalable, the current study also aims to understand women's usage of technology throughout the process of trying to conceive, being pregnant and being a new mother within the local Singapore context.

Studieoversigt

Status

Rekruttering

Betingelser

Detaljeret beskrivelse

Maternal overweight and obesity is a growing public health concern in Singapore. A recent Singaporean prospective cohort study examined 724 pregnant women and reported that 26.2% of the women had a total gestational weight gain (GWG) which exceed the Institute of Medicine's (IOM) 2009 guidelines. When examined based on body mass index (BMI), overweight and obese women had significantly increased risk of gaining gestational weight above IOM recommendations, compared to normal weight women. Higher GWG have previously been linked to adverse maternal and infant outcomes including higher rates of gestational diabetes mellitus (GDM) and primary caesarean delivery, large for age (LGA) infant, macrosomia and increased risk of childhood overweight/obesity. Given the impact of maternal GWG on pregnancy and infant outcomes, there is a need for a targeted behavioural intervention. As effective health behaviour change requires early initiation and maintenance of change, women before, during and after pregnancy should be targeted. Furthermore, high pre-pregnancy BMI have been shown to be linked with increased risk of GDM and type 2 diabetes post-delivery, and higher infant birthweight, child obesity and atypical child neurodevelopment. Accordingly, this highlights the need for early behavioural intervention beginning with women trying to get pregnant. Current studies have focused predominantly on individual factors contributing to maternal obesity in relation to infant outcomes, both immediately postpartum and prospectively into early childhood. Based on Bronfenbrenner's ecological model, key contextual factors involving the micro-, meso-, exo-, macro- and chronosystem are important factors contributing to the efficacy of digital means on health behavioural change among pregnant women. From this theoretical orientation, understanding individual factors involving motivation and contextual influences is central to facilitating health behaviour change. Specifically, elucidating the proximal (e.g. peers, family) and distal factors (e.g. community, health services) embedded within specific cultural contexts ensure sustainability of behaviour change among pregnant women.

As Singapore is a culturally diverse society, there is a need to understand the impact of cultural factors on maternal behaviours and decision making. Accordingly, the current study will consist of a qualitative assessment of 60 participants who will undergo semi-structured interviews with the aim to understand motivations and contextual influences that induce and sustain behaviour change, so as to inform future interventions for women before, during and after pregnancy. As digital health intervention in pregnant women has been shown to be cost-effective and scalable, the current study also aims to understand women's usage of technology throughout the process of trying to conceive, being pregnant and being a new mother within the local Singapore context.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

60

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Studiesteder

      • Singapore, Singapore, 119074
        • Ikke rekrutterer endnu
        • National University Hospital
        • Kontakt:
        • Kontakt:
        • Ledende efterforsker:
          • Shiao-Yng Chan, PhD
        • Underforsker:
          • Yung Seng Lee, PhD
        • Underforsker:
          • Yijuan, Yvonne Lim, MMed
        • Underforsker:
          • Anjian, Andrew Sng, MMed
        • Underforsker:
          • Nicholas Beng Hui Ng, MMed
        • Underforsker:
          • Lin Lin Su, MMed
        • Underforsker:
          • Delicia Shu Qin Ooi, PhD
      • Singapore, Singapore, 117456
        • Rekruttering
        • The N.1 Institute for Health (N.1), NUS, Singapore
        • Kontakt:
        • Kontakt:
        • Underforsker:
          • V Vien Lee, PhD
        • Underforsker:
          • Smrithi Vijayakumar, PhD
        • Underforsker:
          • Qiao Ying Leong, BSc
        • Underforsker:
          • Johan Eriksson, Prof
        • Underforsker:
          • Yoann Sapanel, MBA
        • Underforsker:
          • Ni Yin Lau, BSocSci (Hons)
        • Underforsker:
          • Wei Ying Ng, BSocSci (Hons)

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

21 år til 45 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Women who are actively trying to conceive (pre-pregnancy) or currently in first to third trimester of pregnancy (during pregnancy) or have a child aged 0-2 years (post-pregnancy).

Beskrivelse

Inclusion Criteria:

  • English fluency;
  • Aged 21 years and above;
  • Actively trying to conceive (pre-pregnancy) or currently in first to third trimester of pregnancy (during pregnancy) or have a child aged 0-2 years (post-pregnancy).

Exclusion Criteria:

  • Evidence/diagnosis of cognitive impairment (e.g. history of dementia, intellectual disability, traumatic brain injury);
  • Current diagnosis of psychiatric disorder (e.g. severe anxiety, depression, schizophrenia);
  • Significant hearing impairment;
  • Inability to complete the study at the judgement of the clinician investigators;
  • Women requiring or who had any form of assisted conception.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Pre-pregnancy
During pregnancy
Post-pregnancy

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Experiences and technology usage among women
Tidsramme: 1 year
We will conduct semi-structured interviews with women who are either trying to conceive, pregnant or have a child aged 0 to 2 years. The interviews seek to find out about the participants' pregnancy/maternal-related experiences including the challenges faced, lifestyle changes made, support systems and experience with the health system. Participants will also be asked about their previous and current experiences with technology usage, such as the type of technology used and the purposes of technology usage. Additionally, there will also be two questionnaires, conducted pre- and post-interview, on the participants' demographics and their opinions on technical aspects of digital platforms.
1 year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Dean Ho, Prof, National University of Singapore

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

8. november 2021

Primær færdiggørelse (Forventet)

8. maj 2022

Studieafslutning (Forventet)

8. november 2022

Datoer for studieregistrering

Først indsendt

15. september 2021

Først indsendt, der opfyldte QC-kriterier

28. oktober 2021

Først opslået (Faktiske)

29. oktober 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

10. november 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

8. november 2021

Sidst verificeret

1. november 2021

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Graviditetsrelateret

Abonner